Epidemiology of marginal zone lymphoma

Overview of attention for article published in Annals of Lymphoma, March 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)

Mentioned by

news: 17 news outlets
blogs: 1 blog

twitter: 6 X users
guideline: 1 clinical guideline source

Readers on

mendeley: 108 Mendeley

So far, Altmetric has seen 1 blog post.

InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China

Neuro Central, 12 Aug 2022

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.